• Global cannabidiol market expected to increase almost sixfold by 2025
• CNSC offers powerful line of CBD products under Xceptol brand
• CannAssist has forecast first-year sales of $5 million, with steady sales growth moving forward

With industry experts predicting the stabilization of hemp prices and a more predictable market in 2021 (https://ibn.fm/q7JzX), CannAssist International (OTCQB: CNSC) appears to be ideally situated in a sector forecast for remarkable growth. Owner of Xceptor Labs, CannAssist is a biotechnological pharmaceutical and wellness company that markets a powerful line of cannabidiol (“CBD”) products under the Xceptol brand.

“The hemp market’s volatility appears to be coming to an end with stabilization of hemp prices at the end of 2020,” reported a recent article titled “Greater CBD Market Stability Likely in 2021.” The Hemp Grower article continued, “Adam Koh, Hemp Benchmarks’ editorial director, tells Hemp Grower that after 12–18 months of hemp biomass prices declining, they began to stabilize this past October and even increase slightly in November. This likely foretells a more predictable market in 2021, Koh says.”

That stability, combined with projected growth of the global cannabidiol market, which was valued at $4.6 billion in 2019 and is expected to increase almost sixfold by 2025 (https://ibn.fm/cA61X), creates incredible potential for CannAssist. One of the first U.S.-based CBD companies to have its securities listed for trading on a U.S. public capital market, CannAssist is focused on offering high-quality, high-performance brands, and has several products currently under development.  Based on growing revenue from raw material and retail sales and expanding social media output and the engagement of strategic partners to help CannAssist ‘get the word out’ and growing distribution arrangements in the US and globally, licensing agreements, retail sales and the Xceptol brand’s international distribution, CannAssist has forecast first-year sales of $5 million, with steady sales growth moving forward.

The company’s products are formulated using Xceptor Labs’ exclusive technology, CiBiDinol, and a proprietary process developed by CannAssist founder Mark Palumbo. The approach addresses vital issues with oil-soluble CBD molecules including delivery, bioavailability and short shelf-life. CannAssist notes that CiBiDinol delivers CBD in a format that is more aligned with the body’s natural bioactivity, combining CBD molecules with penetration-enhancing cyclodextrin. The technology enhances CBD stability and absorption through the skin and gut.

Launched in September 2020, CannAssist’s current Xceptol product lineup includes FDA registered topical pain-cream products formulated using its proprietary CiBiDinol technology. CannAssist is eyeing potential expansion into global markets, including all of North America, Central America, South America, South Africa, the EU, the UK and the Philippines. With that expansion in mind, the company is committed to adding to its strategic manufacturing, laboratory and distribution partners establishing strategic partnerships in ingredient sourcing, manufacturing, processing, laboratory, distribution and public relations and legal representation.

Established in May 2017, CannAssist is headquartered in San Diego County, California, and markets its B2B custom and CiBiDinol raw material technology and its consumer line of cannabidiol (“CBD”) products under the Xceptol brand.

For more information, visit the company’s website at www.CannAssistInternational.com.

NOTE TO INVESTORS: The latest news and updates relating to CNSC are available in the company’s newsroom at https://ibn.fm/CNSC

• Cannabis fintech marketplace innovator MAZAKALI is helping investors and issuers navigate the hurdles of an industry experiencing renewed vitality
• A supportive presidential administration along with continued state-level legalization is serving as a boon to cannabis market interests
• Professional sports leagues have become increasingly friendly to player use, reducing or eliminating cannabis-related drug testing protocols and punishments
• Market analysts forecast global revenues of $358.8 billion by 2027, an annual growth rate of 14.3% percent over 2020’s valuation. In the United States, the industry is growing at nearly twice that rate – boasting a projected annual growth of 27% over the next five years

Cannabis marketplace facilitator MAZAKALI is anticipating a bumper year for governmental and private industry policy-making regarding the leafy green plant’s product potential. Now legal under medical supervision in 35 U.S. states and permitted for adult use in 15 states, cannabis is poised to become the best performing asset class of the decade, according to a market forecast published recently by MAZAKALI. The report, titled “Cannabis 2021: Five Things to Watch,” outlines expectations for the rise of cannabis-infused beverages in the United States, improved production of rare cannabinoids through biosynthesis, growing capital infusion, accelerating acceptance under state and local laws, and increasing openness to cannabis’ psychoactive products by world governments on a national scale (https://ibn.fm/P6UlZ). “We’re seeing a huge increase of products in the health and wellness sector and I think we’ll see more women designing cannabis products for women,” infused drinks-maker K-Zen’s CEO, Judy Yee, told Forbes in a recent report (https://ibn.fm/lZIQh). “Women will be a big force in normalizing cannabis,” she predicted. The report also notes that while the NBA is now the only major sports league that suspends players from games for cannabis use, it has also temporarily stopped testing players for the plant amid the pandemic (https://ibn.fm/v47h6). The company applauded the United Nations’ decision in December to accept a recommendation by the World Health Organization to delist cannabis from its most restrictive Schedule IV classification under international drug control treaties.  Its use for non-medical and non-scientific purposes remains in that classification (https://ibn.fm/K2ZuW). The global cannabis market is expected to grow from $140.7 billion in 2020 to $358.8 billion in 2027 at a CAGR of 14.3 percent, according to the most recent Grand View Research analysis (https://ibn.fm/G0Dc9). MAZAKALI uses GreenPapers(R) such as its “Cannabis 2021” report to inform the public about cannabis markets because it believes in the concept of “Authority Through Knowledge” when it comes to helping a company maneuver through the hurdles modern-day market regulations can present on the path to profitability. The company is based in San Francisco and has been supporting cannabis businesses in raising capital and investors in placing capital since 2016. MAZAKALI’s experienced and licensed professionals deliver services to investors that include an online investment marketplace to handle direct investments in a diverse field of vetted opportunities, personalized portfolio management for highly funded clients, and an Outsourced Cannabis Investment Officer (“OCIO”) service to institutions seeking advice on their cannabis portfolio allocation practices. MAZAKALI’s services to issuers include direction through the capital-raising process on a stage-by-stage basis, following them from early preparations through offering structure, modeling, pitch preparation and launch. The company’s intuitive digital interface enables companies to pursue their ambitions with ease and confidence. For more information, visit the company’s website at www.MAZAKALI.com. NOTE TO INVESTORS: The latest news and updates relating to MAZAKALI are available in the company’s newsroom at https://ibn.fm/MAZAKALI

• United Kingdom announces that nation plans to outlaw sale of gasoline-powered vehicles by 2030, full decade ahead of original deadline
• Electric vehicle sales are set to rise by 50% YoY in 2021, with global EV penetration rates forecast to touch 31% by 2030
• Electric vehicles require nearly 80kg of copper during production process versus approximately 25 kilos for internal combustion engine powered vehicle
• Surge in long-term copper demand bodes favorable for Josemaria Resources, with company reportedly attracting attention of global mining giants in recent months

On November 18, 2020, the United Kingdom made the fateful and unexpected decision to ban the sale of new internal combustion engine vehicles in the country from 2030 onwards (https://ibn.fm/6BkSt) — a step that the British Government felt was necessary to achieve its longer-term carbon emission target goals. While the political statement attracted a great deal of attention from environmental sources, it also quietly heralded a titanic shift in copper demand prospects over the next few decades – one that would bode particularly favorably for the prospects of Josemaria Resources (TSX: JOSE) (OTC: JOSMF), a Canadian natural resources company currently working on the development of its flagship Josemaria Project in Argentina’s San Juan province. In essence, a gasoline-powered vehicle is said to require approximately 25 kilograms of copper during its manufacturing process; however, the figure soars astronomically when looked at through the prism of an electric vehicle. The equivalent electric car would need nearly 80 kilograms of copper to build, largely due to the increased use of electronics and cabling included within the vehicle (https://ibn.fm/92zbC). Passenger vehicle sales topped 77.5 million units in 2019, the last year for which normalized data is available. In an eventual future where 100 percent of those vehicles were to be electrified, automobile manufacturers would look to consume approximately 6.2 billion kilograms of copper per annum (assuming 80 kilograms of copper per vehicle); to put that astounding figure into perspective, total mined copper production  in 2019 amounted to an estimated 20 million metric tons (20 billion kilograms) with Fitch estimating that global copper mine production would increase by a relatively anemic 3.1% per annum over the next nine years to 26.8 million metric tons by 2029 (https://ibn.fm/UvLJi). The Josemaria project is a large scale, undeveloped deposit located in Argentina’s San Juan Province with proven and probable reserves of 6.7 billion pounds of copper, 7 million ounces of gold and 30 million ounces of silver. During a recent presentation at the Metals & Mining Live Virtual Investor Conference (https://ibn.fm/Z5ckG), the company revealed that its Argentina-based mine was forecast to generate an average annual production of 136,000 tonnes of copper, 231,000 ounces of gold, and 1,164,000 ounces of silver over its 19-year life span with commercial production set to commence by 2026. The remarkable forecast for Josemaria’s annual copper production – a figure equivalent to nearly 0.7% of annual global copper production, has led the company to attract attention from the rest of the industry. A recent “Dear Retail” article (https://ibn.fm/dSYBx) speculated that Josemaria Resources was on a short list of potential acquisitions that mining giant Barrick Gold may be looking at. The article (https://ibn.fm/UUhUW) noted that Barrick currently owned a copper mine in Zambia as well as interests in two additional projects—one in Chile and one in Saudi Arabia. However, the company’s copper output was relatively small and certainly “no match for copper giants like BHP, Glencore, Freeport-McMoran and Anglo American.” With electric vehicle sales expected to grow by 50 percent year-on-year in 2021, investment bank analysts have now predicted that global EV penetration rates could rise to as much as 31 percent of the global automotive market by 2030 (https://ibn.fm/j0l0v). In such a scenario and in a potential future where the growth in copper demand and supply present a decidedly asymmetric imbalance, a mining project with the characteristics of the Josemaria Project could present an unmissable commercial opportunity for global mining giants. Regardless of whether Josemaria Resources chooses to develop the Josemaria project on its own or opt to recruit the assistance of a larger mining partner, the company seems to be in an enviable sweet spot – possessing an unexploited copper mining asset at the cusp of what may perhaps turn out to be one of the strongest copper bull runs in history. For more information, visit the company’s website at www.JosemariaResources.com. NOTE TO INVESTORS: The latest news and updates relating to JOSMF are available in the company’s newsroom at https://ibn.fm/JOSMF

• SRAX announces blockchain pioneer, digital media veteran Lou Kerner as CEO of BIGtoken
• BIGtoken, a data marketplace that allows users to own and earn from their data, creates data sets that can be accessed by marketers for a fee
• BIGtoken to be spun off into its own publicly-traded company through definitive agreement with Force Protection Video Equipment Corp.

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies, recently announced that Lou Kerner – a prominent digital media expert and cryptocurrency pioneer – will be appointed Chief Executive Officer of BIGtoken, a wholly-owned subsidiary of SRAX. BIGtoken, a data marketplace that allows consumers to earn from the use of their data while creating data sets accessible to marketers for a fee, has recently entered into a definitive agreement with Force Protection Video Equipment Corp. (OTC: FPVD). The transaction will allow SRAX to receive 88.9% of the issued and outstanding shares of FPVD in exchange for 100% of the shares of BIGtoken and, when completed, FPVD will be renamed to BIGtoken Inc. with Mr. Kerner as CEO. “Lou has been working with data and internet startups his entire career. He has a detailed understanding of blockchain and how it is applied to augment business applications,” said SRAX CEO Christopher Miglino (https://ibn.fm/c15im). “Blockchain will play a big part in the future of consumer identity and privacy and we have a shared vision with Lou on what this will look like. Not only is Lou a technology expert, but his knowledge of the capital markets will be a significant asset to BIGtoken as the company is uplisted to a nationally listed exchange.” Mr. Kerner started his career at Goldman Sachs as a Wall Street analyst with a focus on media companies before transitioning to operating technology companies. His first role as CEO was at The .tv Corporation International – a company that operates domain registry services for websites using the .tv domain extension. Following the acquisition of .tv by Verisign in 2001, Mr. Kerner became the CEO of Bolt Media, the dominant social media company prior to MySpace. After his tenure at Bolt, Mr. Kerner became an angel investor and producer of Wall Street-style reports on companies like Facebook before launching a small VC fund in 2012 and joining Flight Ventures – a venture capital firm focused on tech companies based in Israel. Since 2017, Mr. Kerner has been an active analyst, investor, and advisor in the cryptocurrency industry and is currently one of the most followed authors on Medium. He advises many companies in the space that include the Blockchain Coinvestors fund, the Casper protocol, Props – an SEC-approved loyalty program token, and Silver Castle – an institutional-grade digital asset manager. He is also a partner in an AngelList Syndicate that actively invests in crypto projects in addition to being the founder of CryptoMondays – the largest crypto-focused group on the Meetup social network with chapters in over 50 cities across the world. “As the world continues to move to ensure greater internet privacy for consumers, BIGtoken is well-positioned to help brands, media companies, research organizations, and political campaigns efficiently reach consumers via compliant ad targeting and surveys,” said Mr. Kerner. “I further believe BIGtoken will greatly benefit by fully embracing crypto as an alternative reward for our growing consumer base.” SRAX Inc. is a digital marketing and consumer data management technology company that helps companies unlock insights that reveal core consumers and their characteristics across multiple marketing channels. Soon to be spun off into its own publicly-traded company, SRAX’s BIGtoken platform allows internet users to own and earn from their data while creating valuable data sets that can be accessed by marketers for a fee. For more information, visit the company’s website at www.SRAX.com. NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

• Amid increasing concerns about personnel security from criminal elements, autonomous security robot maker Knightscope is advancing efforts to help make America the safest country in the world
• Knightscope’s AI-enhanced robot sentries have been deployed to Fortune 1000 companies, hospitals, police departments, municipalities, utilities and casinos
• The company’s models include stationary robots as well as mobile products that patrol indoor and outdoor locations
• The robots use artificial intelligence and feature 360-degree eye-level HD streaming video, autonomous recharging, face and license plate recognition, and infrared thermal detection to deter crime and transmit safety or investigational information
• The sentries have the added benefit of being unaffected by the infectious contagion hampering the performance of many employees while the COVID pandemic remains in effect

Autonomous robot manufacturer Knightscope aims to make the United States the safest country on earth with the help of its artificial intelligence-enhanced machines. Knightscope’s current product lineup hinges on the performance of its K1 stationary robot, its indoor-roving K3 model and its outdoor perimeter-patrolling K5 sentry. The company’s robotic platform is designed to potentially reduce the costs of providing security while avoiding not only physical obstacles in their path, but some of the emotional limitations of human patrols as well, such as fatigue, boredom, texting and even fear or anger. Far from the armed profile of movie industry Robocops, or even the more real-world use of National Guard forces supporting U.S. Capitol security forces in the wake of this month’s deadly incursion by domestic terrorists against Congress and ahead of the inauguration of President-elect Joe Biden (https://ibn.fm/4vFhz), Knightscope’s robotic patrols surveil property grounds without weapons but provide a deterrent to crime through their capacity to detect, record and communicate details of incidents for further investigation.  They also provide officers and guards unprecedented situational awareness. Knightscope’s machines are in service across the country, having been deployed at numerous Fortune 1000 companies, hospitals, police departments and the Veterans Administration. Features such as 360-degree eye-level HD streaming video, speakers for live or recorded communication, face and license plate recognition, and broadcast signal reception make the robots capable of responding to a variety of scenarios during their patrols. Their thermal anomaly detection technology has also helped alert authorities to the budding possibility of a fire emergency before the situation got out of hand (https://ibn.fm/WoIYY). During the ongoing pandemic crisis, the sentries have the added benefit of being unaffected by a viral illness. While the autonomous robots arose out of the same philosophy propelling the transportation industry toward self-driving cars and shuttles, Knightscope CEO William Santana Li said during a recent fireside chat hosted by IPO Edge that he set aside his automotive industry background for the more market-responsive parallel venture in the realm of security to commercialize AI-driven technology (https://ibn.fm/h3iCZ). “Depending on who you believe, over $80 billion has been invested in self-driving autonomous (automobile) technology. There are 200-plus companies working on it. How many people in the audience did a transport or moved something or moved themselves this week in an autonomous vehicle? Nobody, right? So $80 billion went into the sector, nobody shipped anything that’s commercially viable,” Li said. “I believe Knightscope is the only company in the world operating 24/7/365 across an entire nation, fully autonomous, no human intervention, with real-world clients and real-world environments.” Li’s vision of platform development equates the self-driving car build-up to trying to travel to Pluto before learning to travel to the moon. Knightscope’s security robots are responsive to an actual societal need and represent a logical, incremental approach by the company. The company’s funding profile is backed by more than 18,000 investors (and growing) through its Reg A+ offering, with security officers of large corporations, shopping mall directors, municipal police officers and federal agents on board. Market analysts at Mordor Intelligence foresee the global market for autonomous security robots reaching $3.59 billion by 2025, and its most recent report gives a shout-out to Knightscope’s K5 model by stating it signals significant progress in the technology, adding, “Earlier, these robots had insufficient capabilities; however, with advances in sensor technology and automation capabilities, these robots have been developed to be useful in working applications” (https://ibn.fm/7KdR6). For more information, visit the company’s website at www.Knightscope.com. Visit www.Knightscope.com/invest for a summary of Knightscope as an investment, with a blue Instant Messaging button for direct contact with their CEO. DISCLAIMER: You should read the Offering Circular and risks related to this offering before investing. This Reg A+ offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/Knight

• December 1, 2020 marked one-year anniversary since recreational marijuana use was approved for sale in Michigan
• Retailers have sold approximately $450 million worth of recreational marijuana products over the last year, with sales averaging $13 million per week in recent months
• Gage Cannabis has leveraged upon rising growth rate through rapid store expansion, which will see its store footprint grow by over 10 locations in 2021
• Michigan’s governor recently signed legislation which will allow veterinarians to speak to pet owners about giving cannabis to their animals for therapeutic use

On December 1, 2020, Michigan marked the one-year anniversary following the legalization of recreational marijuana use within the state. Initially approved by voters in November of 2018, retail sales would have to wait a further 13 months until state officials had built a regulatory system to manage the fledgling industry. Gage Cannabis, a leading vertically integrated cannabis operator currently focused exclusively on the Michigan market, has been one of the prime beneficiaries from the legislative measures.

Since retail sales began on December 1, 2019, weekly sales numbers for adult use products have enjoyed a steady climb. Over the past twelve months, retailers have sold approximately $450 million-worth of recreational marijuana products in the state of Michigan – with average sales rising to over $13 million a week in recent months (https://ibn.fm/Hurkh).

“I would say we’re not even close to market saturation yet,” said Michigan Cannabis Industry Association executive director Robin Schneider in relation to explosive growth in sales.

Gage Cannabis has been able to partake in the region’s rapid growth trajectory as a by-product of the company’s aggressive expansion plan – one that has seen them open 6 medical or adult-use locations across the state, with a further 10+ locations slated to open in 2021. The company has also announced its intentions to raise up to $50 million in gross proceeds through a regulation A+ offering (https://ibn.fm/uv2uj), with a portion of the proceeds set to be re-invested towards financing the company’s various growth initiatives.

The new year has brought about the prospect of a further distinctive sub-sector opening within the wider Michigan cannabis market. In early January, Michigan’s governor signed legislation allowing veterinarians to speak to pet owners regarding the possibility of giving cannabis to their animals for therapeutic use (https://ibn.fm/bLRXH). While the US Food and Drug Administration – which also oversees pet foods and drugs – has yet to authorize CBD for pets, sales of CBD products for pets has seen remarkable growth, with total annual sales in the United States rising from a mere $58 thousand in 2016 to over $7.3 million as of 2019, according to market analytics giant Nielsen Global Connect (https://ibn.fm/cmZ56).

Boasting a strong foothold within the domestic Michigan cannabis market and with the potential of further expansion within the state set to vastly expand the company’s total addressable market, Gage Cannabis now finds itself in an advantageous position to fuel its ongoing growth trajectory. With recent weekly growth trends implying potential recreational marijuana sales growth of over 50 percent over the next year, the Michigan cannabis market may just be the place to be.

For more information, visit the company’s website at www.GageUSA.com.

NOTE TO INVESTORS: The latest news and updates relating to Gage Cannabis are available in the company’s newsroom at https://ibn.fm/GAGE

• The number of bladder cancer cases in 2020 is estimated at 81,400, nearly 4.5% of all newly diagnosed cancer cases, and the current bladder cancer research market is projected to grow at a CAGR of 4.03% through 2026
• White light, the most widely accepted current standard of care for bladder cancer removal, may not be the best option in helping to prevent recurrence, leaving hundreds of thousands of patients afraid of relapse
• Blue light has been introduced and proven to detect 25% more tumors, but because of limitations, has not been widely accepted
• Imagin Medical’s i/Blue Imaging System(TM) can be used alongside the current surgical endoscopic tools for a side-by-side comparison of both white and blue-light imaging in real time

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, is focused on establishing new standards of care in the visualization of cancer during minimally invasive procedures. With an initial focus on bladder cancer, the company aims to address the limitations surgeons face during cystoscopies. The current standard of visualizing bladder cancer during surgery is white light illumination, a procedure that has been used for more than three decades and commands 90 percent of the market.

White-light illumination is effective when it comes to visualizing cancerous tumors protruding above the bladder wall, but flat tumors can look the same as normal tissue and are almost impossible to visualize with white light.

These limitations are successfully overcome with the use of blue light. The problem, however, is that blue light cannot be used during removal of the cancer. Surgeons are therefore required to switch back and forth between white light and blue light during surgeries, losing the real-time observation comparison advantage.

Imagin Medical’s proprietary i/Blue Imaging System(TM) addresses the limitations surgeons face in this regard by simultaneously displaying both white-light and blue-light images side by side, in real time.

Using an FDA-approved imaging agent, the i/Blue System is unlike other systems available on the market today in that it can attach to almost any endoscope model that is currently on the market. Due to this compatibility, any hospital adopting the i/Blue Imaging System will be able to do so in a cost-effective manner without needing to replace their current surgical instruments.

The technology has the potential to revolutionize the current standard of care for bladder cancer patients and help position Imagin Medical as a leading provider of effective solutions in the vast market of bladder cancer research and therapeutics. Bladder cancer is the sixth most prevalent form of cancer and the most expensive one to treat in the United States. The number of new bladder cancer cases in the next year is estimated to reach 81,400, or 4.5% of all newly diagnosed cancer cases, while the estimated number of deaths from bladder cancer in likely to reach 17,980, or 3% of all cancer-related deaths (https://ibn.fm/bjiHj).

According to Verified Market Research, the global bladder cancer research market reached $3.43 billion in 2018. Through 2026, the market is expected to grow at a CAGR of 4.03%, resulting in a projected $4.71 billion in total market growth (https://ibn.fm/HkgN1).

Of all the forms of cancer, bladder cancer has one of the highest recurrence rates among all cancer forms. This leaves an estimated 600,000 people living in fear that their cancer will return, according to Imagin Medical. The company is committed to addressing these fears and making the i/Blue System more broadly accessible for the removal of cancer, potentially lowering recurrence rates.

Imagin Medical announced in late November that it had closed the first $750,000 tranche of a proposed offering of up to $3 million of convertible notes. All securities that have been issued in connection with this offering will be subject to the statutory hold period of four months plus a day from the date of issuance (https://ibn.fm/yzjHS).

For more information, visit the company’s website at www.ImaginMedical.com.

NOTE TO INVESTORS: The latest news and updates relating to IMEXF are available in the company’s newsroom at https://ibn.fm/IMEXF

• PacRoots Cannabis updated investors following first successful hemp harvest derived from joint venture with Rock Creek Farms
• Initial harvest yielded 105,000 lbs of biomass of exceptional quality; yield was sold in its entirety to Speakeasy Cannabis Club
• Harvest was particularly remarkable given that it was produced despite region’s poor prevailing weather conditions
• Global CBD oil, consumer health market poised to grow to value of $123.2 billion by 2027

PacRoots Cannabis (CSE: PACR) (OTCQB: PACRF), a Canada-based cannabis company dedicated towards producing premium-quality strains and products by leveraging a genetics-focused approach, has recently updated its investors and stakeholders following the company’s first successful hemp harvest on its 100-acre site situated in British Columbia’s South Okanagan Valley (https://ibn.fm/0lGHr). Following the award for an industrial hemp license by Health Canada on May 22, 2020, which permitted Pac Roots Cannabis Corp. to cultivate, sell, possess and process industrial hemp, the Company entered into a binding letter of intent with Rock Creek Farms to form a joint venture with the intent to plant hemp CBD seedlings on 100-acres of prime arable land in British Columbia (https://ibn.fm/7dMzT). Planting commenced in mid-June 2020, with approximately 130,000 premium hemp CBD plants placed systematically throughout the two 50-acre parcels comprising the site. PacRoots revealed that its initial harvest had been a remarkable success, yielding a quality which was far higher than expected; the Company also announced that the entire biomass yield of over 105 thousand pounds is being processed and sold to Speakeasy Cannabis Club (CSE: EASY).  Furthermore, PacRoots elaborated on its low-cost production capabilities, which the Company believes provides it with a decisive and sustainable competitive advantage while continuing to maintain healthy profit margins. “We are very proud of our team and partners at Rock Creek Farms who have been committed to the vision and dedicated to achieving success […] PacRoots and our partners are thrilled to build on this success as we launch into 2021 with various exciting projects,” said PacRoots Cannabis President and CEO Patrick Elliott in reference to the harvest. The Company also highlighted the remarkable nature of the harvest, given that it had come amid less-than-ideal meteorological conditions. British Columbia’s spring season in 2020 was decidedly atypical, with a wet spring and a cold harvest, while the fall ended earlier than usual with freezing temperatures and snow.  PacRoots and Rock Creek Farms were able to limit the frost exposure and damage to their hemp crop through a series of measures, including staggered planting and harvest, system controls, several varieties of genetics and a strong personnel crew, all of which in combination enabled the joint venture to recover far more biomass than would have been expected. “2020 has thrown many things at us, the latest was snow and freezing weather that broke all records in the area dating back to 1886 when they began keeping records in Rock Creek,” remarked the joint venture’s operation advisor Marc Green. “We feel fortunate to have recovered most of the biomass from the 100-acres while most of our peer group failed to recover any significant yield.” Going forward into 2021, the PacRoots Cannabis – Rock Creek Farms joint venture anticipates a strong planting season, seeking to build upon the lessons learned over the prior season. With the global CBD oil and CBD consumer health market set to grow to a market value of $123.2 billion by 2027 (https://ibn.fm/ubKCP). PacRoots Cannabis Corp. seems well poised to benefit from the explosive growth in demand for their product. For more information, visit the company’s website at www.PacRoots.ca. NOTE TO INVESTORS: The latest news and updates relating to PACR are available in the company’s newsroom at http://ibn.fm/PACR

• Ease of use, compatibility with third-party EEG amplifiers has created diverse target markets for BRSF’s NeuroCap
• Recent forecasts show telemedicine industry expected to experience CAGR of 15.1% through 2027
• BRSF has potential to disrupt sleep industry, which is forecast to reach $585 billion by 2025

Brain Scientific (OTCQB: BRSF) is offering solutions to the EEG industry’s limitations. The current method of administering an EEG is slow and expensive, plus requires specialized EEG technologists and bulky equipment. This essential procedure is not easily accessible to all, particularly those in rural communities, because of the expense and a neurologist shortage.

The NeuroCap(TM) is Brain Scientific’s patented, disposable EEG headset. FDA cleared, the revolutionary device can be set up by any clinical personnel within five minutes. The headset is third-party compatible and has no bulky equipment. The NeuroCap makes EEGs accessible to anyone who needs one.

The ease of use and compatibility with third-party EEG amplifiers has created a diverse target market for NeuroCap. Typically EEGs are administered primarily at hospitals or neurology practices, but the NeuroCap makes EEGs available to other markets not previously seen as viable options.  Two growing industries that Brain Scientific plans to target as potential markets are telemedicine and sleep studies.

Last year — 2020 — saw a significant increase in telemedicine. The CDC reported that the first quarter of 2020 saw an increase of 50% from the previous year while week 13 experienced a 154% increase (https://ibn.fm/hA0Rc).

Dr. John Hixson, an associate professor of neurology at the University of California San Francisco and the San Francisco VA, described the NeuroCap as an attractive device in situations where there is no standard of care currently. “In community hospitals, they typically don’t have EEG resources,” noted Hixon, “Yet the question of whether a person is having a subclinical seizure or not comes up quite frequently” (https://ibn.fm/BwArg).

Nurses at these facilities would be able to apply the headset, collect the EEG signals quickly and then access a neurologist remotely, Hixon explained.

Changes in the CPT Code, or numbers used to identify medical services and procedures furnished by qualified healthcare professionals, show a significant change in outpatient codes, the first large overhaul in more than 25 years (https://ibn.fm/YMfPW). This change reflects the changes within the industry as the demand for telehealth continues to increase.

In 2019, the telemedicine market size was estimated at $41.4 billion globally, and recent forecasts show the industry is expected to experience a compounded annual growth of 15.1% through 2027. Part of this increase is credited to the need for improved care while also reducing the burden on medical professionals (https://ibn.fm/q2Jwp).

Telemedicine is not the only sector in need of portable, low-cost, reliable equipment. The sleep industry is seeing an uptick in clients as 50 to 70 million people in the United States suffer from one or several sleep disorders. With more than 4,700 sleep centers and labs across the country, these potential patients can access the care they need (https://ibn.fm/3G0a0). Many of them will need an EEG as abnormalities in sleep may be a sign of neurologic disorders (https://ibn.fm/56K5T).

There is a move within the sleep clinics to provide at-home sleep studies due to the convenience and lower cost. However, at-home studies only monitor breathing. The addition of the NeuroCap to a sleep clinic’s toolbox will provide higher convenience. With the sleep industry worldwide expected to reach $585 billion by 2025 (https://ibn.fm/JEL1m), this is a lucrative market BRSF has the potential to disrupt.

Brain Scientific is creating innovative ways to make a much-needed medical procedure more accessible to all.

For more information, visit the company’s website at www.BrainScientific.com.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

• Following the success of the Venue Bubble and Travel Bubble projects, Loop has partnered with Draganfly Inc. to launch the first Film Bubble for a major motion picture in January 2021
• The film and television industry has seen a significant drop in revenue, and the Film Bubble is positioned to make sets safer with the technology provided by Draganfly
• Effective December 11, 2020, Mark Lotz took over the position of Chief Financial Officer after the resignation of Abbey Abdiye

Loop Insights (TSX.V: MTRX) (OTCQB: RACMF), an innovative Internet of Things (“IoT”) technology company that delivers contactless solutions, including venue management, personalized engagement, and AI-driven insights, is partnering with Draganfly Inc. (CSE: DFLY) (OTCQB: DFLYF) (FSE: 3U8)) to launch the first “Film Bubble,” a solution designed to help keep movie sets safer and operational during the coronavirus pandemic (https://ibn.fm/tJAKt). The Film Bubble provides another major opportunity for Loop as a spin-off of the recently successful NCAA Venue Bubble and Travel Bubble projects. According to Loop CEO Rob Anson, the Film Bubble will provide a great showcase for the company’s film industry solution as well as additional opportunities for travel, venue, and other healthcare applications Loop Insights has been working on. The Film Bubble will be launched for a major motion picture scheduled to commence filming in January 2021. At this time, the names of the motion picture and the actors are being kept confidential until filming begins. Under the partnership agreement, Loop Insights and Draganfly will combine technologies into Loop’s Venue Bubble solution with the ultimate goal of making the film and television industry safer to resume production, resulting in higher revenue and employment opportunities. “Film industry investors, insurance companies, unions, and guilds are all seeking this type of solution to keep workers safe and protect their investments,” Draganfly CEO Cameron Chell said. Draganfly provides Safe Set Solutions for the global film and television production industry using ground-based technology for symptom pre-screening, elevated body temperature measurement, and social distancing display. The Film Bubble solution comes at the right time for an industry that has reported billions in losses as a result of the coronavirus pandemic closing down movie theaters and production. In 2019, the North American box office amounted to $11.32 billion in total earnings and employed over 456 thousand people with several hundred thousand more employees in Canada and other countries worldwide (https://ibn.fm/hVmFz). This past November, AMC Theatres announced that they had seen a 91% drop in their revenues during the most recent earnings period resulting in a loss of $906 million in this quarter alone. The overall global entertainment industry is also projected to lose $160 billion of growth over the next five years (https://ibn.fm/Kr0Wj). “The addition of Draganfly’s Safe Set Solutions to our Venue Bubble Platform creates an instant and powerful Film Bubble solution for an industry that has suffered catastrophic losses in 2020 and can’t afford to stay shut down for a minute longer,” Anson said. “We are extremely proud to have jointly delivered a solution to the film industry that will allow them to safely get their crews, actors, and supporting infrastructure back to work and generating prosperity, the ripple effects of which reverberate around the world.” On the same day the Film Bubble partnership was made public, Loop Insights announced the appointment of a new Chief Financial Officer. The previous CFO, Abbey Abdiye, resigned from the company to pursue other career opportunities. He is replaced by Mark Lotz, who took over the position effective December 11, 2020 (https://ibn.fm/Vicrd). Lotz is a Chartered Professional Accountant with 26 years of post-qualification experience. His experience spans across a broad cross-section of industries that include SaaS, mining, manufacturing, financial service, and technology. Lotz has a Bachelor’s degree in Business Administration with a dual Economics major. Backed by Amazon’s Partner Network, Loop has developed a line of powerful technologies that are simple to use but designed to transform industries. Fobi, an IoT device that is designed to seamlessly integrate with any existing point of sale infrastructure, collects 100% of the transactional data and sends it to the cloud. SmarTap is Loop’s Near Field Communication (“NFC”) device that enables consumers to check-in using a “tap” and their smartphone’s NFC compatibility. SmarTap offers a contactless consumer experience and connects with the cloud via LTE or WiFi to securely transmit data. Loop Cloud is the middle ground where Fobi and SmarTap’s information meets, being stored digitally and creating a database for the company and their clients. When paired with either Loop solution, the Loop Cloud creates a way for the business to transform their edge-based legacy systems into a unified database. For more information, visit the company’s website at www.LoopInsights.ai. NOTE TO INVESTORS: The latest news and updates relating to RACMF are available in the company’s newsroom at https://ibn.fm/RACMF